Health-related quality of life in elderly patients with familial hypercholesterolemia

International Journal of Technology Assessment in Health Care

Volumn 24, Issue 2, 2008, Pages 228-234

  Hyttinen, Laura ^a   Kekäläinen, Päivi ^a   Vuorio, Alpo F ^b   Sintonen, Harri ^c   Strandberg, Timo E ^d  

^a NORTH KARELIA CENTRAL HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF OULU   (Finland)

Author keywords

Aged; Familial hypercholesterolemia; Health related quality of life; Statin medication

Indexed keywords

FAMILIAL HYPERCHOLESTEROLEMIA; HEALTH-RELATED QUALITY OF LIFE; STATIN MEDICATION;

DISEASES; DRUG THERAPY; PATIENT MONITORING;

HEALTH CARE;

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ELDERLY CARE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FINLAND; HEALTH CARE QUALITY; HUMAN; LIFESTYLE MODIFICATION; MALE; MORBIDITY; QUALITY OF LIFE; SOCIOECONOMICS; STANDARDIZATION; SURVIVAL;

AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; COMORBIDITY; CORONARY DISEASE; FEMALE; HEALTH BEHAVIOR; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; QUALITY OF LIFE; SOCIOECONOMIC FACTORS;

EID: 42049103261     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462308080318     Document Type: Article

References (24)

1. Aalto A-M, Aro AR, Teperi J. RAND-36 as a measure of health-related quality of life. Reliability, construct validity, and reference values in the Finnish general population. Helsinki: Stakes, Research Reports 101; 1999 (in Finnish).
2. Aromaa A, Koskinen S, eds. Health and functional capacity in Finland. Baseline results of the Health2000 health examination survey. Publications of the National Public Health Institute B3/2002. Helsinki: National Public Health Institute; 2002 (in Finnish).
3. Bardage C, Isacson DGL. Hypertension and health-related quality of life: An epidemiological study in Sweden. J Clin Epidemiol. 2001;54:172-181.
4. Brezinka V, Kittel F. Psychosocial factors of coronary heart disease in women: A review. Soc Sci Med. 1996;42:1351-1365.
5. Brown N, Melville M, Gray D, et al. Quality of life four years after acute myocardial infarction: Short form 36 scores compared with a normal population. Heart. 1999;81:352-358.
6. De Jongh S, Kerckhoffs MC, Grootenhuis MA, et al. Quality of life, anxiety and concerns among statin-treated children with familial hypercholesterolemia and their parents. Acta Paediatr. 2003;92:1096-1101.
7. Duncan PW, Samsa GP, Weinberger M, et al. Health status of individuals with mild stroke. Stroke. 1997;28:740-745.
8. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, et al. eds. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill; 2001:2863-2913.
9. Gulliford MC, Mahabir D. Relationship of health-related quality of life to symptom severity in diabetes mellitus: A study in Trinidad and Tobago. J Clin Epidemiol. 1999;52:773-780.
10. Hemingway H, Nicholson A, Stafford M, Roberts R, Marmot M. The impact of socioeconomic status on health functioning as assessed by the SF-36 questionnaire: The Whitehall II Study. Am J Public Health. 1997;87:1484-1490.
11. Hollman G, Gullberg M, Ek A-C, Eriksson M, Olsson AG. Quality of life in patients with familial hypercholesterolemia. J Intern Med. 2002;251:331-337.
12. Lyons RA, Lo SV, Littlepage BN. Comparative health status of patients with 11 common illnesses in Wales. J Epidemiol Community Health. 1994;48:388-390.
13. Regidor E, Barrio G, de la Fuente L, et al. Association between educational level and health related quality of life in Spanish adults. J Epidemiol Commun Health. 1999;53:75-82.
14. Retterstol K, Stugaard M, Gorbitz C, Ose L. Results of intensive long-term treatment of familial hypercholesterolemia. Am J Cardiol. 1996;78:1369-1374.
15. Scientific Steering Committee on behalf of the Simon Broome Register Group. Mortality in treated heterozygous familial hypercholesterolaemia: Implications for clinical management. Atherosclerosis. 1999;142:105-112.
16. Sintonen H. The 15D instrument of health-related quality of life: Properties and applications. Ann Med. 2001;33:328-336.
17. Soljanlahti S, Autti T, Lauerma K, et al. Familial hypercholesterolemia patients treated with statins at no increased risk for intracranial vascular lesions despite increased cholesterol burden and extracranial atherosclerosis. Stroke. 2005;36:1572-1574.
18. Soto M, Failde I, Marquez S, et al. Physical and mental component summaries score of the SF-36 in coronary patients. Qual Life Res. 2005;14:759-768.
19. Sprangers MAG, de Regt EB, Andries F, et al. Which chronic conditions are associated with better or poorer quality of life? J Clin Epidemiol. 2000;53:895-907.
20. Strandberg TE, Strandberg A, Rantanen K, et al. Low cholesterol, mortality, and quality of life in old age during a 39-year follow-up. J Am Coll Cardiol. 2004;44:1002-1008.
21. Torres MS, Calderon SM, Diaz IR, et al. Health-related quality of life in coronary heart disease compared to norms in Spanish population. Qual Life Res. 2004;13:1401-1407.
22. Van Jaarsveld CHM, Sanderman R, Ranchor AV, et al. Gender-specific changes in quality of life following cardiovascular disease: A prospective study. J Clin Epidemiol. 2002;55:1105-1112.
23. Vuorio AF, Turtola H, Piilahti K-M, et al. Familial hypercholesterolemia in the Finnish North Karelia. A molecular, clinical and genealogical study. Arterioscler Thromb Vasc Biol. 1997;17:3127-3138.
24. Westin L, Carlsson R, Erhardt L, Cantor-Graae E, McNeil T. Differences in quality of life in men and women with ischemic heart disease. A prospective controlled study. Scand Cardiovasc J. 1999;33:160-165.